| For: | Kourie HR, Gharios J, Elkarak F, Antoun J, Ghosn M. Is metastatic pancreatic cancer an untargetable malignancy? World J Gastrointest Oncol 2016; 8(3): 297-304 [PMID: 26989465 DOI: 10.4251/wjgo.v8.i3.297] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i3/297.htm |
| Number | Citing Articles |
| 1 |
Qiangsheng Hu, Yi Qin, Bo Zhang, Chen Liang, Shunrong Ji, Si Shi, Wenyan Xu, Jinfeng Xiang, Dingkong Liang, Quanxing Ni, Xianjun Yu, Jin Xu. FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1. Oncology Reports 2017; 38(4) doi: 10.3892/or.2017.5856
|
| 2 |
Qingcai Meng, Si Shi, Chen Liang, Dingkong Liang, Jie Hua, Bo Zhang, Jin Xu, Xianjun Yu. Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling. Oncogene 2018; 37(44) doi: 10.1038/s41388-018-0392-z
|
| 3 |
FERMÍN MAR-AGUILAR, CRISTINA RODRÍGUEZ-PADILLA, DIANA RESÉNDEZ-PÉREZ. Web-based tools for microRNAs involved in human cancer. Oncology Letters 2016; 11(6) doi: 10.3892/ol.2016.4446
|
| 4 |
Elzbieta Nowara, Joanna Huszno. Masitinib plus gemcitabine for personalized treatment of PDAC patients with overexpression of ACOX1. Expert Review of Precision Medicine and Drug Development 2016; 1(6) doi: 10.1080/23808993.2016.1257911
|
| 5 |
Jeffrey Q. Nguyen, Rosalyn B. Irby. TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells. Cancer Biology & Therapy 2017; 18(1) doi: 10.1080/15384047.2016.1252880
|
| 6 |
Derya KIVRAK SALİM, Mustafa YILDIZ. COMPARISON OF THREE FIRST-LINE TREATMENTS IN ADVANCED PANCREATIC CANCER PATIENTS OLDER THAN 65 YEARS OF AGE: SINGLE-CENTRE EXPERIENCE. Turkish journal of Geriatrics 2019; 22(4) doi: 10.31086/tjgeri.2020.116
|
| 7 |
Barbara Grünwald, Jennifer Vandooren, Michael Gerg, Kaarin Ahomaa, Annique Hunger, Sonja Berchtold, Sophia Akbareian, Susanne Schaten, Percy Knolle, Dylan R. Edwards, Ghislain Opdenakker, Achim Krüger. Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow. Molecular Cancer Research 2016; 14(11) doi: 10.1158/1541-7786.MCR-16-0180
|
| 8 |
Joseph Kattan, Hampig Raphael Kourie, Elie El Rassy, Tarek Assi, Tony Ibrahim, Marwan Ghosn. Dilemma of first line regimens in metastatic pancreatic adenocarcinoma. World Journal of Gastroenterology 2016; 22(46): 10124-10130 doi: 10.3748/wjg.v22.i46.10124
|
| 9 |
Abdel Hadi Hajjar, Roland Eid, Fady Gh Haddad, Hampig Raphael Kourie. FOLFIRINOX: A New Standard of Care In The Adjuvant Setting of Resectable Pancreatic Adenocarcinomas. Future Oncology 2019; 15(17) doi: 10.2217/fon-2019-0136
|